Aimia Inc. (TSX:AIM)
Canada · Delayed Price · Currency is CAD 2.820
+0.040 (1.44%)
Apr 8, 2026, 10:30 AM EST
Aimia Employees
Aimia had 2,385 employees as of December 31, 2025. The number of employees increased by 2,367 or 13,150.00% compared to the previous year.
Employees
2,385
Change
2,367
Growth
13,150.00%
Revenue / Employee
214.51K CAD
Profits / Employee
14.59K CAD
Market Cap
247.47M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,385 | 2,367 | 13,150.00% |
| Dec 31, 2022 | 18 | 0 | - |
| Dec 31, 2021 | 18 | 0 | - |
| Dec 31, 2020 | 18 | -427 | -95.96% |
| Dec 31, 2019 | 445 | -2,455 | -84.66% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Neo Performance Materials | 1,524 |
| AirBoss of America | 1,204 |
| 5N Plus | 849 |
| Nano One Materials | 104 |
| EcoSynthetix | 28 |
Aimia News
- 14 days ago - Aimia Inc (AIMFF) Q4 2025 Earnings Call Highlights: Navigating Challenges and Capitalizing on ... - GuruFocus
- 14 days ago - Q4 2025 Aimia Inc Earnings Call Transcript - GuruFocus
- 15 days ago - AIMIA REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - Benzinga
- 20 days ago - AIM ImmunoTech Stock Today: AIM Surges 44% on Massive Volume After Patent Approval and Cancer Trial Progress - International Business Times (Australia)
- 20 days ago - Why Is AIM ImmunoTech Stock Gaining Today? - Benzinga
- 21 days ago - AIM ImmunoTech Gains Japanese Patent Approval for Cancer Treatment - GuruFocus
- 23 days ago - AIMIA DECLARES PREFERRED SHARE DIVIDENDS - Benzinga
- 4 weeks ago - Verdict parent company GlobalData moves to Main Market of LSE - Verdict